As we come to the close of 2022, we look upon these past 12 months as among the most pivotal in the history of both the National Alopecia Areata Foundation and the community we serve. 2022 was the year our research efforts came to fruition with the first FDA-approved treatment for alopecia areata. Read the story of how it happened. This special Treatment Development Program Impact Report celebrates 12 years of NAAF research efforts which our community helped make possible.
